DOVA - Dova Pharmaceuticals, Inc.
We couldn't determine Recommendation based on the data we have.

Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Dova Pharmaceuticals, Inc. (DOVA) -
Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was founded on March 24, 2016 and is headquartered in Durham, NC.
Exchange - NASDAQ
Industry - Pharmaceuticals: Major
Sector - Health Technology

Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2021 and future.